Organon & Co. Common Stock (NY:OGN)

13.77 -0.04 (-0.28%)

Delayed Quote Updated: 3:30 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

October 01, 2026

From Organon & Co.

Via Business Wire

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

September 14, 2026

From Organon & Co.

Via Business Wire

This House of Representative Just Sold Up To $30K In Organon Stock ↗

August 13, 2026

A report on August 12, 2026 shows that Representative Kevin Hern from Oklahoma sale stock in Organon (NYSE:OGN), valued between $2,002 and $30,000. According to the August filing, the transaction...

Via Benzinga

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability

August 11, 2026

From Organon & Co.

Via Business Wire

Organon Announces Quarterly Dividend

July 31, 2026

From Organon & Co.

Via Business Wire

New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1

July 24, 2026

From Organon & Co.

Via Business Wire

Organon & Co. Shareholders Clear Sun Pharma Merger Deal ↗

July 23, 2026

Shareholders of Organon & Co. (NYSE:OGN) approved the company’s proposed merger agreement with Sun Pharmaceutical Holdings USA, Inc. at a virtual special meeting held Wednesday, according to...

Via MarketBeat

Topics Stocks

Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing

July 16, 2026

From Organon & Co.

Via Business Wire

Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting

July 07, 2026

From Organon & Co.

Via Business Wire

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

June 24, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

June 22, 2026

From Organon & Co.

Via Business Wire

Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders

June 16, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)

June 16, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

June 10, 2026

From Organon & Co.

Via Business Wire

Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders

June 09, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)

June 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon to Present New Research on Access and Value at ISPOR 2026

May 15, 2026

From Organon & Co.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX)

May 14, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders

May 06, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether MKC, LEG, OGN, KW are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

May 05, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether AVNS, OGN, ESQ, VRE are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates

April 30, 2026

Pharmaceutical company Organon (NYSE:OGN) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 3.5% year on year to $1.46 billion. Its ...

Via StockStory

Topics Artificial Intelligence

Organon Reports Results for the First Quarter Ended March 31, 2026

April 30, 2026

From Organon & Co.

Via Business Wire

Organon Cancels First Quarter Earnings Call

April 29, 2026

From Organon & Co.

Via Business Wire

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

April 28, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders

April 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal ↗

April 27, 2026

Today, April 27, 2026, a jumbo all-cash buyout and merger-arb dynamics put Organon in focus.

Via The Motley Fool

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.